The CDC is investigating a growing cluster of illnesses across four states linked to glutathione injections — specifically those made with dietary supplement grade glutathione rather than pharmaceutical grade. Over 25 cases have been identified, with symptoms including fever, chills, pain, dizziness, and sepsis-like reactions, some serious enough to require hospitalization.

The FDA has been clear: dietary supplement grade glutathione is not an appropriate ingredient for injectable drugs. While glutathione is a naturally occurring antioxidant that has been explored for uses ranging from skin care to managing symptoms in patients with AIDS or cystic fibrosis, no FDA-approved glutathione injectable products exist. Two Texas compounding pharmacies have already issued recalls after their products tested positive for excessive endotoxin levels — the likely culprit behind the severe reactions.

Key Takeaways:

• Clinicians should verify the source of glutathione used by compounders before recommending or administering injectable formulations
• Patients asking about glutathione injections for wellness or skin care should be counseled on the current safety risks
• Any adverse events should be reported to the FDA and CDC promptly

Why it matters: With compounded injectables operating in a regulatory gray zone, this outbreak highlights the real dangers of using non-pharmaceutical grade ingredients in sterile drug preparations — and underscores the need for clinician vigilance and patient education.